Clinical trials recruiting for Locally Advanced or Metastatic NSCLC
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 3 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ASKC202+ Limertinib | 1 |
| HS-10504 | 1 |
| Pemetrexed + Cisplatin /Carboplatin | 1 |
Self-screener
Recruiting trials
- A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
- ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy
Related conditions
Trials recruiting for Locally Advanced or Metastatic NSCLC often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Locally Advanced or Metastatic NSCLC trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.